Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
18%
OVERLAP
BY WEIGHT
BY WEIGHT
14
# OF OVERLAPPING HOLDINGS
WDNA
90
HOLDINGS
17%
ALSO IN CANC
CANC
48
HOLDINGS
29%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 2.7% | 5.2% | 2.7% |
|
BRIDGEBIO PHARMA, INC. | 2.4% | 4.9% | 2.4% |
|
AMGEN INC | 1.7% | 3.3% | 1.7% |
 |
NOVARTIS AG | 1.7% | 4.4% | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.5% | 3.5% | 1.5% |
WDNA Overweight Relative to CANC
|
NATERA INC | 3.7% |
|
TWIST BIOSCIENCE CORP. | 3.3% |
 |
NOVOZYMES A/S-B SHARES | 2.9% |
|
VERICEL CORPORATION | 2.6% |
|
BLUEPRINT MEDICINES CORP. | 2.6% |
|
VERACYTE INC | 2.1% |
|
AGIOS PHARMACEUTICALS INC | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
|
UNITED THERAPEUTICS CORP | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% |
WDNA Underweight Relative to CANC
|
ROCHE HOLDINGS LTD-SPONS ADR | -5.3% |
|
REVOLUTION MEDICINES, INC. | -4.2% |
 |
ASTRAZENECA PLC | -4.1% |
|
EXELIXIS INC | -4.1% |
 |
MERUS N.V. | -3.8% |
|
NUVALENT, INC. CLASS A | -3.5% |
|
SUMMIT THERAPEUTICS INC | -3.1% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.9% |
|
NOVARTIS AG | -2.8% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -2.7% |